IPP Bureau
Sun Pharma appoints former PwC India COO Satyavati Berera as independent director
By IPP Bureau - April 05, 2026
Board approves five-year appointment, subject to shareholder nod through postal ballot
Max Healthcare allots 57,461 equity shares under ESOP 2022
By IPP Bureau - April 05, 2026
Paid-up equity capital rises to Rs 973.19 crore following allotment to eligible employees
KIMS enters Kerala with 20-year operations pact for Avitis Super Speciality Hospital in Palakkad
By IPP Bureau - April 05, 2026
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
Dr Jitendra Singh calls for India-led biosimilar insulin scale-up amid global supply concerns
By IPP Bureau - April 05, 2026
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
CSIR-CFTRI strengthens food innovation ecosystem with BioNEST launch, 26 startups supported
By IPP Bureau - April 05, 2026
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
AstraZeneca combo therapy shows breakthrough in liver cancer trial
By IPP Bureau - April 05, 2026
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
SRM Prime Hospital's India-first heart procedure saves 73-year-old after standard options fail
By IPP Bureau - April 05, 2026
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
Danone India sets record with 20,911 healthcare pledges to fight anemia
By IPP Bureau - April 05, 2026
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
Cupid deposits Rs. 82.88 crore for strategic stake in Baazar Style Retail
By IPP Bureau - April 05, 2026
The deal gives Cupid immediate access to Style Baazar’s fast-growing network of over 260 stores
Senores makes bold US push with new federal-focused JV
By IPP Bureau - April 05, 2026
Company leadership is framing the move as transformational.
Innovent Biologics’ OLN324 shows breakthrough results in vision disease study
By IPP Bureau - April 05, 2026
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Concord Biotech acquires Celliimune to accelerate DNA-engineered cancer therapies
By IPP Bureau - April 04, 2026
Rs 66 lakh acquisition will support DNA engineering and novel cell-gene therapy alternatives to conventional chemotherapy
Sun Pharma flags mixed Fibromun trial results, advances new Phase III study in soft tissue sarcoma
By IPP Bureau - April 04, 2026
The company has highlighted setbacks in Phase II studies while outlining fresh regulatory and late-stage development plans for Fibromun and Nidlegy
Jan Vishwas Bill 2026 decriminalises minor health sector offences, eases compliance burden
By IPP Bureau - April 04, 2026
Parliament clears reform bill replacing jail terms for procedural lapses with graded monetary penalties across key health laws
